Primary relevance to vitamin D Vitamin D is a stated subject of this paper.
Vitamin D is a stated subject of this paper; the supporting source evidence is shown below.
Why this paper is included
Supporting source evidence:
The meta-analysis showed that the decrease in CRP in the nutritional vitamin D intervention group was significantly higher than that in the control group [MD −3.15, 95% confidence interval (CI; −4.46, −1.84), P < 0.05].
Source: Abstract. View original paper
Relevance classification does not establish study quality, causation or editorial approval.
Study design Review / evidence synthesis.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Meta-analysis reported · Blinding not applicable to this review · Research setting awaiting verification
How this paper was classified
Automatic source-based classification; awaiting editorial verification. This is not a quality score.
The role of nutritional vitamin D on microinflammation and nutritional status in maintenance hemodialysis patients: a meta-analysis of randomized controlled trials
Source: Article title.
Publisher article type: systematic-review
Source: Publisher publication metadata.
What the study types mean
- Systematic review
- Uses explicit methods to identify, assess and summarise research on a defined question.
- Scoping review
- Maps the extent and characteristics of research on a topic.
- Narrative review
- Discusses existing research; systematic-review methods have not been established by this classification.
- Review / evidence synthesis
- Reviews existing research; the exact review methods need further assessment.
- Randomised controlled trial
- Assigns participants or groups to comparison interventions by chance.
- Non-randomised intervention study
- Examines an intervention without random allocation.
- Cohort study
- Examines exposures and outcomes over time within a defined group.
- Case-control study
- Compares people with an outcome against people without it, examining exposures.
- Cross-sectional study
- Examines a population at a particular point in time.
- Observational study
- Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
- Case report
- Describes an individual case.
- Case series
- Describes a group of individual cases.
- Secondary analysis
- Analyses existing study data; this paper is not automatically another independent trial.
- Laboratory study
- Investigates biological processes in a laboratory setting.
- Qualitative study
- Examines experiences or meanings using qualitative methods.
- Genetic instrumental-variable study
- Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
- Study protocol
- Describes planned methods and is not evidence that the planned study has reported results.
- Multiple reported designs
- More than one design is explicitly reported; examine the supporting methods.
- Study design awaiting verification
- The available source does not establish a sufficiently clear study design.
Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.
Abstracts
The role of nutritional vitamin D on microinflammation and nutritional status in maintenance hemodialysis patients: a meta-analysis of randomized controlled trials
Review / evidence synthesis · Frontiers in Nutrition · 2026
Original publication title
The role of nutritional vitamin D on microinflammation and nutritional status in maintenance hemodialysis patients: a meta-analysis of randomized controlled trials
Copyright © 2026 Li, Xu, Wang and Wu.
Original publication · Publisher record · CC BY 4.0
Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.
At a glance
Abstract: What background does the paper provide?
Microinflammation is widespread in Maintenance hemodialysis (MHD) patients. The continuous interaction of microinflammation and malnutrition is an independent risk factor for the clinical prognosis of MHD patients. Nutritional vitamin D deficiency is closely related to chronic kidney disease inflammation, but whether correcting this deficiency can improve microinflammation in the MHD population remains unclear.
Source: BackgroundAbstract: What methods does the paper describe?
Studies published up to March 1, 2025 were included. Risk of bias was assessed using the Cochrane tool. RevMan 5.4 and Stata 17 were used for analyses, with heterogeneity assessed and random-effects models applied. Key outcomes included CRP, serum albumin, TNF-α, IL-1β, immunoreactive Parathyroid Hormone (iPTH), adverse events, hypercalcemia, and hyperphosphatemia.
Source: MethodsAbstract: Results
A total of 617 patients in eight randomized controlled trials were included. The experimental group interventions were nutritional vitamin D, while those of the control group were placebo. The meta-analysis showed that the decrease in CRP in the nutritional vitamin D intervention group was significantly higher than that in the control group [MD −3.15, 95% confidence interval (CI; −4.46, −1.84), P < 0.05]. Subgroup analysis demonstrated that nutritional vitamin D supplementation not only reduced CRP in MHD patients with baseline vitamin D deficiency, but also in those with normal vitamin D baseline levels [MD −2.64, 95% CI (−4.47, −0.81), P < 0.05; MD −3.97, 95% CI (−5.78, −2.17), P < 0.05].
The increase in serum albumin in the vitamin D group was more significant than in the control group [MD 0.55, 95% CI (0.10, 1.01), P < 0.05]. iPTH decreased more significantly in the vitamin D group than in the control group [SMD −0.56, 95% CI (−1.07, −0.05), P < 0.05]. In terms of safety, the overall incidence of adverse reactions in the nutritional vitamin D group was similar to that in the control group (P = 0.09). Moreover, no significant differences were found in the incidence of hypercalcemia and hyperphosphatemia between the two groups (P = 0.15, P = 0.32).
Source: ResultsAbstract: Conclusion
Nutritional vitamin D supplementation may improve microinflammation and nutritional status in MHD patients, with potential benefits for bone metabolism and no apparent increase in the risk of hypercalcemia or hyperphosphatemia.
Source: ConclusionAuthors’ abstract
Background
Microinflammation is widespread in Maintenance hemodialysis (MHD) patients. The continuous interaction of microinflammation and malnutrition is an independent risk factor for the clinical prognosis of MHD patients. Nutritional vitamin D deficiency is closely related to chronic kidney disease inflammation, but whether correcting this deficiency can improve microinflammation in the MHD population remains unclear.
Methods
Studies published up to March 1, 2025 were included. Risk of bias was assessed using the Cochrane tool. RevMan 5.4 and Stata 17 were used for analyses, with heterogeneity assessed and random-effects models applied. Key outcomes included CRP, serum albumin, TNF-α, IL-1β, immunoreactive Parathyroid Hormone (iPTH), adverse events, hypercalcemia, and hyperphosphatemia.
Results
A total of 617 patients in eight randomized controlled trials were included. The experimental group interventions were nutritional vitamin D, while those of the control group were placebo. The meta-analysis showed that the decrease in CRP in the nutritional vitamin D intervention group was significantly higher than that in the control group [MD −3.15, 95% confidence interval (CI; −4.46, −1.84), P < 0.05]. Subgroup analysis demonstrated that nutritional vitamin D supplementation not only reduced CRP in MHD patients with baseline vitamin D deficiency, but also in those with normal vitamin D baseline levels [MD −2.64, 95% CI (−4.47, −0.81), P < 0.05; MD −3.97, 95% CI (−5.78, −2.17), P < 0.05].
The increase in serum albumin in the vitamin D group was more significant than in the control group [MD 0.55, 95% CI (0.10, 1.01), P < 0.05]. iPTH decreased more significantly in the vitamin D group than in the control group [SMD −0.56, 95% CI (−1.07, −0.05), P < 0.05]. In terms of safety, the overall incidence of adverse reactions in the nutritional vitamin D group was similar to that in the control group (P = 0.09). Moreover, no significant differences were found in the incidence of hypercalcemia and hyperphosphatemia between the two groups (P = 0.15, P = 0.32).
Conclusion
Nutritional vitamin D supplementation may improve microinflammation and nutritional status in MHD patients, with potential benefits for bone metabolism and no apparent increase in the risk of hypercalcemia or hyperphosphatemia.
Publication and source details
Original title: The role of nutritional vitamin D on microinflammation and nutritional status in maintenance hemodialysis patients: a meta-analysis of randomized controlled trials
Chen Li; Shuangshuang Xu; Yu Wang; Meiyan Wu
Frontiers in Nutrition · 2026
* Correspondence: Meiyan Wu, renalwmy@jlu.edu.cnCopyright © 2026 Li, Xu, Wang and Wu.2026Li, Xu, Wang and Wuhttps://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.The author(s) declared that financial support was received for this work and/or its publication. This study was supported by Medical and Health Talents Special Project of Jilin Province (Department of Finance of Jilin Province) (JLSWSRCZX2025-106).Repository JATS snapshot; version as supplied
Source retrieved: 2026-11-10T10:26:58.700114+00:00
DOI: 10.3389/fnut.2026.1767616 · PMC13260404